David E Schteingart: Influence Statistics

David E Schteingart

David E Schteingart

Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan | Department of Internal Medicine, University of Michigan Medical Center, Ann ...

David E Schteingart: Expert Impact

Concepts for which David E Schteingart has direct influence: Adrenal cancer , Adrenocortical carcinoma , Adrenal scintigraphy , Cortisol secretion , Cushings syndrome , Depressed mood , Neuroendocrine tumors .

David E Schteingart: KOL impact

Concepts related to the work of other authors for which for which David E Schteingart has influence: Adrenocortical carcinoma , Cushing syndrome , Hippocampal volume , Pituitary adenomas , Cortisol levels , Adrenal cortex , Chronic stress .

KOL Resume for David E Schteingart

Year
2015

Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan

2013

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA

2012

Division of Metabolism, Endocrinology and Diabetes, Endocrine Oncology Program, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.

2010

Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Rm 5570, MSRB 2, 1150 West Medical Center Dr, Ann Arbor MI 48109, USA.

2009

Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.

University of Michigan Medical School, BSRB 1502, 109 Zina Pitcher Place, 48109-2200, Ann Arbor, MI, USA

2006

Endocrinology and Metabolism (D.E.S.) Ann Arbor, Michigan 48109

Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, Michigan Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, Michigan

2005

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA.

2003

Department of Internal Medicine (DES), University of Michigan Medical School, Ann Arbor, Michigan, USA

2002

Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan Medical School, 1150 West Medical Center Dr., Ann Arbor, MI 48109, USA

2001

University of Michigan Medical School, Ann Arbor, MI

Departments of Internal Medicine (D.E.S., R.S.B., D.A.A.), Ann Arbor, Michigan 48109

2000

University of Michigan, Ann Arbor, USA

1999

Department of and Department of Internal Medicine (DES), University of Michigan Medical School, Ann Arbor, Michigan, USA

1997

Department of Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109-0678, USA, US

1996

Division of Endocrinology and Metabolism, University of Michigan Medical Center, Ann Arbor, MI, USA

1995

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109-0722, U.S.A.

USIntenal Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109

1993

Departments of Internal Medicine, Pharmacology, and Pathology, Medical School and College of Pharmacy, University of Michigan, 48109, Ann Arbor, MI, USA

1992

Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A

1991

Professor of Internal Medicine, Interim Chief, Division of Endocrinology and Metabolism, University of Michigan Medical Center, Ann Arbor, Michigan

1989

Professor of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Medical School, Ann Arbor, Michigan

1987

Third Department of Internal Medicine, Kyushu University

1986

David E. Schteingart, M.D., is Professor, Department of Internal Medicine, School of Public Health, University of Michigan, USA

From the Departments of Pathology, Surgery (Section of Neurosurgery), and Internal Medicine (Division of Endocrinology and Metabolism), The University of Michigan Medical Center, Ann Arbor, Michigan

1981

From the Department of Medicine, Sections of Allergy and Endocrinology, University of Michigan School of Medicine Ann Arbor, Mich., USA

1980

Neuro psychological Laboratory, University of Michigan, 1111 East Catherine Street, Ann Arbor, Michigan 48109

1979

Ann Arbor, Michigan, USA

1974

Department of Internal Medicine, Section on Endocrinology and Metabolism, University of Michigan, Ann Arbor, MI 48104

1973

From the Section of Urology, Department of Surgery and Sections of Endocrinology and Metabolism, and Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

1972

Department of Internal Medicine Section on Endocrinology and Metabolism University of Michigan Ann Arbor, MI 48104

1968

Departments of Internal Medicine (Section of Endocrinology and Metabolism) and Pathology of the University of Michigan Medical Center, Ann Arbor, Mich

1965

Department of Internal Medicine, Division of Endocrinology and Metabolism and The Metabolism Research Unit University of Michigan, Ann Arbor, Mich.

Prominent publications by David E Schteingart

KOL-Index: 17623 . Obesity and starvation have opposing affects on normal physiology and are associated with adaptive changes in hormone secretion. The effects of obesity and starvation on thyroid hormone, GH, and cortisol secretion are summarized in Table 1. Although hypothyroidism is associated with some weight gain, surveys of obese individuals show that less than 10% are hypothyroid. Discrepancies have ...
Known for Thyroid Hormone | Cortisol Secretion | Anorexia Nervosa | Gh Increase
KOL-Index: 11146 . PurposeInsulin-like growth factor 1 receptor signaling through upregulation of the stimulatory ligand IGF-II has been implicated in the pathogenesis of adrenocortical carcinoma. As there is a paucity of effective therapies, this dose expansion cohort of a phase 1 study was undertaken to determine the safety, tolerability, pharmacokinetics, and effects on endocrine markers of figitumumab in ...
Known for Adrenocortical Carcinoma | Figitumumab Patients | Solid Tumors | Growth Hormone
KOL-Index: 10759 . Cushing's syndrome is a complex endocrine condition with potential serious complications if untreated or inadequately treated. Transsphenoidal surgery with resection of a pituitary adenoma is successful in 75 - 80% of patients, but approximately 20 - 25% show persistence of Cushing's, and a similar proportion may experience recurrence within 2 - 4 years post-op. When surgery fails, medical ...
Known for Medical Treatment | Cushings Syndrome | Patients Cushing | Cortisol Secretion
KOL-Index: 8898 . BACKGROUND: Transsphenoidal surgery is the standard approach for treating Cushing disease. Evidence is needed to document effectiveness. OBJECTIVE: To analyze results of transsphenoidal surgery in 276 consecutive patients, including 19 children. METHODS: Medical records were reviewed for patients treated initially with surgery for Cushing disease from 1980 to 2012. Radiographic features, ...
Known for Cushing Disease | Transsphenoidal Surgery | Remission Rates | Patients Microadenomas
KOL-Index: 8152 . Mitotane is an important adrenalytic drug for the treatment of adrenal cancer whose use is limited by toxicity. Reports from another laboratory indicated that a methylated homolog of Mitotane (Mitometh) tested in guinea pigs possessed comparable adrenalytic activity but was less toxic than Mitotane. This observation prompted us to undertake a comparative study of these two drugs on the ...
Known for Adrenal Cortex | Carcinoma Cell | Activity Mitotane | Treatment Dogs
KOL-Index: 8048 . Patients with chronic hypercortisolemia due to Cushing's syndrome (CS) exhibit cognitive dysfunction. Because glucocorticoid excess is associated with hippocampal damage in animals, and the hippocampus participates in learning and memory, we explored the relationships between hippocampal formation (HF) volume, memory dysfunction, and cortisol levels in 12 patients with CS. After magnetic ...
Known for Cortisol Levels | Hippocampal Formation | Verbal Recall | Cushings Syndrome
KOL-Index: 7993 . Adrenocortical carcinomas are rare, highly malignant tumors that account for only 0.2% of deaths due to cancer. Given the limited number of patients seen in most medical centers with this diagnosis, series usually reported are small and clinical trials not randomized or blinded. In an attempt to answer important questions concerning the management of patients with adrenal cancer, a ...
Known for Adrenal Cancer | Management Patients | Preclinical Studies | Adrenocortical Carcinomas
KOL-Index: 7392 . Because patients with Cushing' syndrome (CS) and Major depressive disorder (MDD) share features of hypercortisolism and the depressive syndrome, we compared electro-encephalographic (EEG) sleep in patients with pituitary-ACTH-dependent Cushing's syndrome (Cushing's disease, CD), patients with ACTH-independent Cushing's syndrome (AICS), patients with major depressive disorder (MDD), and ...
Known for Patients Cushing Syndrome | Depressive Disorder | Cushings Disease | Sleep Rem
KOL-Index: 7174 . BACKGROUND: Facial emotion perception (FEP) is a critical human skill for successful social interaction, and a substantial body of literature suggests that explicit FEP is disrupted in major depressive disorder (MDD). Prior research suggests that weakness in FEP may be an important phenomenon underlying patterns of emotion-processing challenges in MDD and the disproportionate frequency of ...
Known for Major Depressive Disorder | Inferior Frontal | Women Mdd | Leftward Bias
KOL-Index: 7075 . Patients with Cushing's syndrome (CS) frequently have sleep complaints. We evaluated sleep polysomnographically in 22 patients, including 17 with pituitary-ACTH-dependent Cushing's disease (CD) and five with CS from an adrenal tumor. Data were compared to healthy controls of comparable age. Seven patients (32%) demonstrated at least mild sleep apnea (> or = 9.4 events/hour), and four of 22 ...
Known for Sleep Apnea | Cushing Syndrome | Rem Latency | Normal Subjects
KOL-Index: 6931 . A 49-year old woman with a 5-year history of Cushing's syndrome was evaluated. Biochemical measurements revealed high cortisol and adrenocorticotropic hormone (ACTH) levels consistent with the ACTH-dependent type of Cushing's syndrome. However, the source of ACTH seemed to be autonomous as she demonstrated abnormal feedback control, with lack of response to metyrapone and high coses of ...
Known for Ectopic Pituitary Adenoma | Cushings Syndrome | Sphenoid Sinus | Adrenocorticotropic Hormone
KOL-Index: 6676 . Thirty-five consecutive patients with Cushing's syndrome were studied prospectively prior to treatment. A consistent constellation of psychiatric disturbances was found, including impairments in affect (depressed mood and crying), cognitive functions (decreased concentration and memory), and vegetative functions (decreased libido and insomnia). A statistically significant relationship was ...
Known for Depressed Mood | Psychiatric Manifestations | Hormone Levels | Cushings Syndrome
KOL-Index: 6379 . BACKGROUND: Decreased hippocampal volume is observed in patients with Cushing's syndrome and other conditions associated with elevated cortisol levels, stress, or both. Reversibility of hippocampal neuronal atrophy resulting from stress occurs in animals. Our study investigated the potential for reversibility of human hippocampal atrophy. METHODS: The study included 22 patients with ...
Known for Hippocampal Atrophy | Cushing Disease | 22 Patients | Resonance Imaging

Key People For Adrenal Cancer

Top KOLs in the world
#1
Massimo Terzolo
adrenocortical carcinoma adrenal incidentalomas adjuvant mitotane
#2
XAVIER Y Bertagna
adrenocortical tumors cushings disease ectopic acth syndrome
#3
Bruno Allolio
adrenocortical carcinoma adrenal insufficiency heart failure
#4
Alfredo Berruti
adrenocortical carcinoma prostate cancer neuroendocrine differentiation
#5
Martin Jean Schlumberger
thyroid cancer adrenocortical carcinoma radioactive iodine
#6
Murray, F Brennan
gastric cancer soft tissue pancreatic adenocarcinoma

Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan | Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA | Division of Metabolism, Endocrinology and Diabetes, Endocri